A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis
- 1 September 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (5) , 27-33
- https://doi.org/10.1016/s0002-9149(02)02556-0
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- PPARγ Is Not a Critical Mediator of Primary Monocyte Differentiation or Foam Cell FormationBiochemical and Biophysical Research Communications, 2002
- Prevention of fat-induced insulin resistance by salicylateJournal of Clinical Investigation, 2001
- Insulin Resistance and Its Treatment by ThiazolidinedionesRecent Progress in Hormone Research, 2001
- Role of NF-κB in immune and inflammatory responses in the gutGut, 1998
- Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.Journal of Clinical Investigation, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.Journal of Clinical Investigation, 1994
- Salicylates as Hypoglycemic AgentsDiabetes Care, 1982
- Lipid peroxide levels of serum lipoprotein fractions of diabetic patientsBiochemical Medicine, 1981
- Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusionAmerican Heart Journal, 1976